slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 29,251-29,280
Pages 1,379
Rows per page 30
Component
29,251-29,280 of 41,369
03
The background contains scattered DNA base letters (A, T, C, G), suggesting a biotech or healthcare context.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
04
The chart uses a gradient arrow to emphasize the scale of 12.2M participants compared to other biobanks.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide highlights the breadth of genetic reporting and emphasizes FDA authorizations.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
18
The slide features a background pattern of DNA base pairs (A, T, C, G) and a central circle with the number 3.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide uses a gradient background and visual representations of mobile app screens to illustrate the integration of genetic insights into primary care.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
26
The slide features a gradient background with scattered DNA base letters (A, T, C, G) and a central circle containing the number 4.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
44
Uses heatmaps to visualize genetic associations with various disease phenotypes.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
55
The slide highlights a 34% YoY increase in Therapeutics R&D spending.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
38
The slide uses a high-quality photo of a researcher to emphasize R&D focus.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
46
Uses a process flow to illustrate the 'playbook' for growth.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
47
Uses a process-flow diagram to illustrate the business model components.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
56
3M | Investor Day Presentation Deck | 94 slides3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
63
Includes a specific guidance metric for organic sales growth.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
09
Uses a additive framework to show how different growth levers combine.Talkspace | Investor Conference Presentation Deck | 14 slides · Talkspace
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
Uses a simple additive framework to show how three distinct strategies combine to drive growth.Talkspace | Investor Conference Presentation Deck | 14 slides · Talkspace
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a process flow diagram to map technology features to specific stages of the patient care journey.Talkspace | Investor Conference Presentation Deck | 14 slides · Talkspace
Conference presentation Investor relations 1 hit
04
Uses a honeycomb/hexagonal visual motif to represent interconnected firm pillars.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
05
The slide uses a hexagonal grid motif to present core value propositions.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
21
The slide uses a split-screen layout to contrast organizational structure (Shared Teams) with thematic investment focus (Shared Themes).TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations Beat · Team1 hit
28
The table is categorized by investment strategy (Capital, Growth, Impact, Real Estate).TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
31
The chart illustrates the bridge between the starting balance, realized gains, and value creation to reach the ending balance.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
01
Vigil Neuroscience | IPO Presentation Deck | 54 slidesVigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
19
The slide uses box plots to compare control vs mVGL101 groups across six different gene expression categories.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
25
The slide uses a comparison matrix to establish a biological rationale for targeting these pathways.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
26
The slide uses a causal chain diagram to link genetic mutations to cellular outcomes, supported by empirical data from Kempthorne et al. 2020.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
27
Slide 27 of a pitch deck. Contains three distinct chart/image panels showing efficacy of VGL101.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
28
PoM = Proof of Mechanism; ALSP = Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
40
The slide uses box plots to compare control vs VG-3440 across six different biological metrics.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit